Pacific Biosciences of California, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Pacific Biosciences of California, Inc. (PACB) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 1.80% for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-05.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2015-11-05
- Pacific Biosciences of California, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2015-09-30 was 1.80%, a 5.26% decline year-over-year.
- Pacific Biosciences of California, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2015-06-30 was 1.70%, a 10.53% decline year-over-year.
- Pacific Biosciences of California, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2015-03-31 was 1.60%, a 15.79% decline year-over-year.
- Pacific Biosciences of California, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2014-09-30 was 1.90%, a 5.56% increase year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month |
|---|---|---|---|
| 2015-09-30 | 1.80% 10-Q · filed 2015-11-05 | 1.60% 10-Q · filed 2015-11-05 | |
| 2015-06-30 | 1.70% 10-Q · filed 2015-08-05 | 1.60% 10-Q · filed 2015-08-05 | |
| 2015-03-31 | 1.60% 10-Q · filed 2015-05-05 | ||
| 2014-09-30 | 1.90% 10-Q · filed 2015-11-05 | 1.90% 10-Q · filed 2015-11-05 | |
| 2014-06-30 | 1.90% 10-Q · filed 2015-08-05 | 1.90% 10-Q · filed 2015-08-05 | |
| 2014-03-31 | 1.90% 10-Q · filed 2015-05-05 | ||
| 2013-09-30 | 1.80% 10-Q · filed 2014-11-05 | 1.10% 10-Q · filed 2014-11-05 | |
| 2013-06-30 | 1.10% 10-Q · filed 2014-08-05 | 1.10% 10-Q · filed 2014-08-05 | |
| 2013-03-31 | 1.10% 10-Q · filed 2014-05-08 | ||
| 2012-09-30 | 0.90% 10-Q · filed 2013-11-12 | 1.10% 10-Q · filed 2013-11-12 | |
| 2012-06-30 | 1.00% 10-Q · filed 2013-08-09 | 1.10% 10-Q · filed 2013-08-09 | |
| 2012-03-31 | 1.10% 10-Q · filed 2013-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |